The current stock price of ELMD is 29.02 USD. In the past month the price increased by 1.61%. In the past year, price decreased by -2.52%.
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 25.29 | 219.41B | ||
| ISRG | INTUITIVE SURGICAL INC | 67.95 | 207.41B | ||
| BSX | BOSTON SCIENTIFIC CORP | 33.35 | 145.84B | ||
| SYK | STRYKER CORP | 27.88 | 140.43B | ||
| BDX | BECTON DICKINSON AND CO | 14.23 | 58.56B | ||
| IDXX | IDEXX LABORATORIES INC | 56.49 | 56.88B | ||
| EW | EDWARDS LIFESCIENCES CORP | 32.91 | 49.08B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 19.21 | 40.16B | ||
| RMD | RESMED INC | 25.35 | 36.63B | ||
| DXCM | DEXCOM INC | 36.79 | 26.69B | ||
| PODD | INSULET CORP | 64.09 | 20.60B | ||
| ZBH | ZIMMER BIOMET HOLDINGS INC | 11.63 | 18.64B |
Electromed, Inc. engages in the development, manufacture, marketing, and sale of medical equipment. The company is headquartered in New Prague, Minnesota and currently employs 177 full-time employees. The company went IPO on 2010-08-13. The company applies High Frequency Chest Wall Oscillation (HFCWO) technologies in pulmonary care for patients of all ages. The SmartVest Clearway System consists of an inflatable therapy garment, a programmable air pulse generator and a patented single-hose that delivers air pulses from the generator to the garment to create oscillatory pressure on the chest wall. The SmartVest Clearway is designed for comfort and convenience, so patients can readily fit therapy into their daily routines. The SmartVest System is primarily prescribed for patients with bronchiectasis, cystic fibrosis, and neuromuscular conditions such as cerebral palsy and amyotrophic lateral sclerosis. The company also markets the Single Patient Use (SPU) SmartVest and SmartVest Wrap to health care providers in the acute care setting.
ELECTROMED INC
500 Sixth Avenue Nw
New Prague MINNESOTA 56071 US
CEO: Kathleen S. Skarvan
Employees: 177
Phone: 19527589299
Electromed, Inc. engages in the development, manufacture, marketing, and sale of medical equipment. The company is headquartered in New Prague, Minnesota and currently employs 177 full-time employees. The company went IPO on 2010-08-13. The company applies High Frequency Chest Wall Oscillation (HFCWO) technologies in pulmonary care for patients of all ages. The SmartVest Clearway System consists of an inflatable therapy garment, a programmable air pulse generator and a patented single-hose that delivers air pulses from the generator to the garment to create oscillatory pressure on the chest wall. The SmartVest Clearway is designed for comfort and convenience, so patients can readily fit therapy into their daily routines. The SmartVest System is primarily prescribed for patients with bronchiectasis, cystic fibrosis, and neuromuscular conditions such as cerebral palsy and amyotrophic lateral sclerosis. The company also markets the Single Patient Use (SPU) SmartVest and SmartVest Wrap to health care providers in the acute care setting.
The current stock price of ELMD is 29.02 USD. The price decreased by -1.29% in the last trading session.
ELMD does not pay a dividend.
ELMD has a ChartMill Technical rating of 8 out of 10 and a ChartMill Fundamental rating of 7 out of 10.
10 analysts have analysed ELMD and the average price target is 36.72 USD. This implies a price increase of 26.53% is expected in the next year compared to the current price of 29.02.
The Revenue of ELECTROMED INC (ELMD) is expected to grow by 13.84% in the next year. Check the estimates tab for more information on the EPS, Sales, EBIT and EBITDA future analyst estimates.
ChartMill assigns a technical rating of 8 / 10 to ELMD. When comparing the yearly performance of all stocks, ELMD turns out to be only a medium performer in the overall market: it outperformed 59.9% of all stocks.
ChartMill assigns a fundamental rating of 7 / 10 to ELMD. ELMD gets an excellent profitability rating and is at the same time showing great financial health properties.
Over the last trailing twelve months ELMD reported a non-GAAP Earnings per Share(EPS) of 0.93. The EPS increased by 29.17% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 11.78% | ||
| ROA | 14.01% | ||
| ROE | 17.44% | ||
| Debt/Equity | 0 |
10 analysts have analysed ELMD and the average price target is 36.72 USD. This implies a price increase of 26.53% is expected in the next year compared to the current price of 29.02.
For the next year, analysts expect an EPS growth of 28.75% and a revenue growth 13.84% for ELMD